Resource Center
Resource Center
New approaches to ending vertical transmission of hepatitis B overlap with HIV reduction strategies.
Read more
CHAI supported an analysis, published in Clinical Infectious Diseases, identifying readily available, generic HepC treatments that have been successfully used as second-line therapy for patients in Egypt, Georgia, and Myanmar.
Read more
Unitaid and the Clinton Health Access Initiative, Inc. (CHAI) announce pricing agreement with pharmaceutical company Hetero Labs LTD to make available generic version of best-in-class second-line therapy for people living with HIV.
Read more
A full list of sessions that CHAI is participating in at the Internationl AIDS Society conference.
Read more
CHAI presents cost-effectiveness modeling framework at IAS 2021 to understand the role of multipurpose prevention technologies in HIV prevention and family planning.
Read more
Our monthly check-in with staff from around the world. Learn more about the people who work at CHAI.
Read more
Through this MOU, GARDP, CHAI and Shionogi will use their collective expertise to increase access to cefiderocol in low- and middle-income countries.
Read more
On World Population Day, Caitlin Glover, Senior Director for Global Sexual and Reproductive Health at CHAI, reflects on women’s reproductive health and rights.
Read more
CHAI today announced that Joy Phumaphi, Botswana’s former Minister of Health, and Ann Veneman, the former Executive Director of UNICEF, have been named interim co-CEOs.
Read moreCHAI interviewed individuals who are at high risk of contracting HIV in South Africa to understand their experiences with facilities that initiated them on PrEP and the factors that helped them adhere to treatment.
Read more